Immunoblot analysis of anti-Ureaplasma urealyticum antibody in pregnant women and newborn infants.

Journal Article

The purpose of the present study was to determine the frequency in which antibody reactive to Ureaplasma urealyticum could be detected in a population of pregnant women and newborn infants. Serum samples from a prospective cohort of 80 healthy, U. urealyticum culture-positive and culture-negative pregnant women and a retrospective cohort of 522 infants born at between 25 and 42 weeks of gestation were studied by immunoblot analysis. Cultures of specimens from the lower genital tract were positive for U. urealyticum for 83% of the pregnant women, and serum immunoglobulin G (IgG) antibody which reacted to U. urealyticum was detectable in 93% of the pregnant women. Samples from five women (8%) had increases in the number of anti-U. urealyticum IgG bands over the course of the pregnancy. Samples from four of these five women had corresponding increases in the number of antibody bands present in IgA immunoblots. Six of the 522 samples from newborns or cord blood (1.1%) were positive for anti-U. urealyticum IgA; 5 of these 6 samples were also positive for IgM. The six anti-U. urealyticum IgA-positive infants were distributed as follows; 3 of 67 (4.5%) infants were delivered at 25 to 30 weeks of gestation, 3 of 176 (1.7%) infants were delivered at 31 to 34 weeks of gestation, and 0 of 279 infants were delivered at > or = 35 weeks of gestation. An antibody response to U. urealyticum can be detected in pregnant women and preterm infants and may serve as a marker of infection.

Full Text

Duke Authors

Cited Authors

  • Cunningham, CK; Bonville, CA; Hagen, JH; Belkowitz, JL; Kawatu, RM; Higgins, AM; Weiner, LB

Published Date

  • September 1996

Published In

Volume / Issue

  • 3 / 5

Start / End Page

  • 487 - 492

PubMed ID

  • 8877123

Pubmed Central ID

  • 8877123

International Standard Serial Number (ISSN)

  • 1071-412X


  • eng

Conference Location

  • United States